What is Market Size for WOMEN'S HEALTH DIAGNOSTICS MARKET?

 The growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe, increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers support the growth of the market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128928901



Diagnosis and treatment of problems and diseases that can harm a woman's physical and mental health is called women's health checkup.

Market Segmentation

Based on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests.

Based on end user, the women’s health diagnostics market is segmented into hospitals & clinics, diagnostic & imaging centers, and home care settings. The hospitals & clinics segment accounted for the largest share of the women’s health diagnostics market

Regional Analysis

The Asia Pacific women’s health diagnostics market is expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare infrastructures, growing per capita incomes, and the rising focus of key market companies in this region are major factors driving the growth of the APAC women’s health diagnostics market.

Key Market Players

The prominent players in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Abbott Laboratories (US), Siemens AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), and Becton, Dickinson and Company (US).

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=128928901

Expected Revenue Growth:

The global women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period

Hologic, Inc. holds the leading position in the women’s health diagnostics market, owing to its robust portfolio of breast imaging products and related accessories. Hologic has expanded its product portfolio through insight-driven innovation and strategic M&As to establish its position in the market.

Comments

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Endoscopy Equipment Market Set to Reach USD 53.54 Billion by 2030 | Key Trends, Growth Drivers & Forecast

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™